No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
APLT250117P1500
- 0.50
- 0.000.00%
15min DelayClose Dec 20 16:00 ET
0.00High0.00Low
0.50Open0.50Pre Close0 Volume201 Open Interest1.50Strike Price0.00Turnover124.06%IV-13.64%PremiumJan 17, 2025Expiry Date0.62Intrinsic Value100Multiplier25DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9336Delta0.5138Gamma1.41Leverage Ratio-0.0006Theta-0.0006Rho-1.31Eff Leverage0.0003Vega
Intraday
- 5D
- Daily
News
William Blair Downgrades Applied Therapeutics(APLT.US) to Hold Rating
William Blair Downgrades Applied Therapeutics (APLT) to a Hold
RBC Capital Maintains Applied Therapeutics(APLT.US) With Hold Rating, Cuts Target Price to $1.5
Applied Therapeutics Is Maintained at Sector Perform by RBC Capital
Applied Therapeutics Analyst Ratings
Applied Therapeutics CEO Shendelman Steps Down